文献速递瓣膜外科

无支架生物瓣术后主动脉瓣再手术的近期与远期结局

Aortic Valve Reoperation After Stentless Bioprosthesis: Short- and Long-Term Outcomes.
PubMed 文献 · Ann Thorac Surg · 2018-04-03

该回顾性分析纳入1997年至2017年间143例因无支架主动脉瓣生物瓣衰败行开放再手术的患者。再手术30天死亡率为1%、院内死亡率为2%,5年和10年生存率分别为83%和57%。

要点

  • 无支架瓣再手术30天死亡率为1%,院内死亡率为2%。
  • 再手术原因:结构性瓣膜衰败占68%,感染性人工瓣膜心内膜炎占32%。
  • 5年和10年生存率分别为83%和57%。

核心结论

  • 无支架瓣植入后行主动脉瓣再手术的围术期死亡率低,远期生存良好。

研究设计与样本

  • 1997年至2017年回顾性分析143例因无支架主动脉瓣生物瓣衰败行开放再手术的患者,评估近期与远期结局。

主要发现

  • 初次手术为Freestyle(Medtronic, Minneapolis, MN)者中二叶式主动脉瓣占107/143(75%),120/143(84%)行改良主动脉根部置换。
  • 首次手术至再手术间隔为9年(范围5.4至11.8年),感染性心内膜炎患者为4.1年(范围1.8至7.1),短于结构性瓣膜衰败患者的10.4年(范围8.1至12.4,p < 0.001)。
  • 再手术时中位年龄为59岁(范围50至67)。
  • 再手术原因为结构性瓣膜衰败占68%,感染性人工瓣膜心内膜炎占32%。
  • 合并手术包括冠状动脉旁路移植(13%)、二尖瓣手术(4%)、升主动脉及主动脉弓置换(42%)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Limited data are available regarding outcomes for stentless aortic valve reoperation. The reported reoperative mortality has been unacceptably high. METHODS: Between 1997 and 2017, a retrospective analysis was performed on 143 patients who underwent open aortic valve reoperations for failed stentless aortic valve bioprostheses. We evaluated both short-term and long-term outcomes on this cohort of patients. RESULTS: Bicuspid aortic valve was present in 107 of 143 patients (75%) at the time of the initial Freestyle (Medtronic, Minneapolis, MN) procedure, and 120 of 143 patients (84%) underwent a modified inclusion aortic root replacement procedure. The interval from first operation to reoperation was 9 years (range, 5.4 to 11.8), which was significantly shorter for patients with infectious endocarditis (4.1 years; range, 1.8 to 7.1) compared with patients with structural valvular deterioration (10.4 years; range, 8.1 to 12.4, p < 0.001). The median age at the time of reoperation was 59 years (range, 50 to 67). Aortic valve reoperation was performed for structural valve deterioration in 68% cases compared with 32% for infectious prosthetic valve endocarditis. Concomitant surgery included coronary artery bypass (13%), mitral valve surgery (4%), and ascending aorta and arch replacement (42%). The 30-day and inhospital mortality was 1% and 2%, respectively. The composite outcome including myocardial infarction, stroke, new-onset renal failure on hemodialysis, and operative mortality was 4%. The 5-year and 10-year Kaplan-Meier survival after reoperation for failed stentless valve was 83% (95% confidence interval: 73% to 89%) and 57% (95% confidence interval: 36% to 74%). CONCLUSIONS: Aortic valve reoperation after stentless valve implantation can be performed with low operative mortality and favorable long-term survival.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Yang B, Patel HJ, Norton EL, et al. Aortic Valve Reoperation After Stentless Bioprosthesis: Short- and Long-Term Outcomes. Ann Thorac Surg. 2018. PMID: 29625103. doi:10.1016/j.athoracsur.2018.02.073

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。